Particle radiation alters expression of matrix metalloproteases resulting in ECM remodeling in human lens cells

2007 ◽  
Vol 46 (2) ◽  
pp. 187-194 ◽  
Author(s):  
P. Y. Chang ◽  
K. A. Bjornstad ◽  
C. J. Rosen ◽  
S. Lin ◽  
E. A. Blakely
2007 ◽  
Vol 48 (9) ◽  
pp. 4192 ◽  
Author(s):  
Lisa M. Hodgkinson ◽  
George Duncan ◽  
Lixin Wang ◽  
Caroline J. Pennington ◽  
Dylan R. Edwards ◽  
...  
Keyword(s):  

2005 ◽  
Vol 80 (6) ◽  
pp. 885-895 ◽  
Author(s):  
Lixin Wang ◽  
I. Michael Wormstone ◽  
John R. Reddan ◽  
George Duncan

2000 ◽  
Vol 154 (5) ◽  
pp. 477-484 ◽  
Author(s):  
P. Y. Chang ◽  
K. A. Bjornstad ◽  
E. Chang ◽  
M. McNamara ◽  
M. H. Barcellos-Hoff ◽  
...  

2008 ◽  
Vol 86 ◽  
pp. 0-0 ◽  
Author(s):  
IM WORMSTONE ◽  
JA ELDRED ◽  
LJ DAWES ◽  
JR REDDAN ◽  
L WANG
Keyword(s):  

Cells ◽  
2019 ◽  
Vol 8 (10) ◽  
pp. 1269
Author(s):  
Dewi ◽  
O’Connor

Cataract is a leading cause of blindness worldwide. Currently, restoration of vision in cataract patients requires surgical removal of the cataract. Due to the large and increasing number of cataract patients, the annual cost of surgical cataract treatment amounts to billions of dollars. Limited access to functional human lens tissue during the early stages of cataract formation has hampered efforts to develop effective anti-cataract drugs. The ability of human pluripotent stem (PS) cells to make large numbers of normal or diseased human cell types raises the possibility that human PS cells may provide a new avenue for defining the molecular mechanisms responsible for different types of human cataract. Towards this end, methods have been established to differentiate human PS cells into both lens cells and transparent, light-focusing human micro-lenses. Sensitive and quantitative assays to measure light transmittance and focusing ability of human PS cell-derived micro-lenses have also been developed. This review will, therefore, examine how human PS cell-derived lens cells and micro-lenses might provide a new avenue for development of much-needed drugs to treat human cataract.


2002 ◽  
Vol 75 (5) ◽  
pp. 583-590 ◽  
Author(s):  
L Liu ◽  
C.A Paterson ◽  
D Borchman
Keyword(s):  

Author(s):  
Katie L Land ◽  
Madison E Lane ◽  
Ava C Fugate ◽  
Patrick R Hannon

Abstract Phthalates are solvents and plasticizers found in consumer products including cosmetics, food/beverage containers, housing materials, etc. Phthalates are known endocrine-disrupting chemicals that can directly target the ovary, potentially causing defects in ovulation and fertility. Women are exposed to multiple different phthalates daily, therefore this study investigated the effects of an environmentally relevant phthalate mixture (PHTmix) on ovulation. Ovulation is initiated by the luteinizing hormone (LH) surge, which induces prostaglandin (PG) production, progesterone (P4)/progesterone receptor (PGR) signaling, and extra-cellular matrix (ECM) remodeling. We hypothesized that the PHTmix would directly inhibit ovulation by altering the levels of PGs, P4/PGR, and enzymes involved in ECM remodeling. Antral follicles from CD-1 mice were treated with vehicle control alone (dimethylsulfoxide, DMSO), hCG alone (LH analog), and hCG+PHTmix (1-500μg/ml), and samples were collected across the ovulatory period. The PHTmix decreased ovulation rates at all doses tested in a dose dependent manner when compared to hCG. PG levels were decreased by the PHTmix when compared to hCG, which was potentially mediated by altered levels of PG synthesis (Ptgs2) and transport (Slco2a1) genes. The PHTmix altered P4 and Pgr levels when compared to hCG, leading to decreases in downstream PGR-mediated genes (Edn2, Il6, Adamts1). ECM remodeling was potentially dysregulated by altered levels of ovulatory mediators belonging to the matrix metalloproteases and plasminogen activator families. These data suggest that phthalate exposure inhibits ovulation by altering PG levels, P4/PGR action, and ECM remodeling.


2019 ◽  
Vol 20 (16) ◽  
pp. 3847 ◽  
Author(s):  
Daniel Young ◽  
Nabangshu Das ◽  
Anthonia Anowai ◽  
Antoine Dufour

Matrix metalloproteinases (MMPs) have been studied in the context of cancer due to their ability to increase cell invasion, and were initially thought to facilitate metastasis solely through the degradation of the extracellular matrix (ECM). MMPs have also been investigated in the context of their ECM remodeling activity in several acute and chronic inflammatory diseases. However, after several MMP inhibitors failed in phase III clinical trials, a global reassessment of their biological functions was undertaken, which has revealed multiple unanticipated functions including the processing of chemokines, cytokines, and cell surface receptors. Despite what their name suggests, the matrix aspect of MMPs could contribute to a lesser part of their physiological functions in inflammatory diseases, as originally anticipated. Here, we present examples of MMP substrates implicated in cell signaling, independent of their ECM functions, and discuss the impact for the use of MMP inhibitors.


Sign in / Sign up

Export Citation Format

Share Document